RCDTF
Price
$65.44
Change
+$9.40 (+16.77%)
Updated
Jun 13 closing price
Capitalization
12.3B
RHHBF
Price
$314.81
Change
+$3.10 (+0.99%)
Updated
Aug 15 closing price
Capitalization
254.82B
Interact to see
Advertisement

RCDTF vs RHHBF

Header iconRCDTF vs RHHBF Comparison
Open Charts RCDTF vs RHHBFBanner chart's image
Recordati Industria Chimica e Farmaceutica S.p.A
Price$65.44
Change+$9.40 (+16.77%)
Volume$300
Capitalization12.3B
Roche Holding
Price$314.81
Change+$3.10 (+0.99%)
Volume$1
Capitalization254.82B
RCDTF vs RHHBF Comparison Chart in %
Loading...
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RCDTF vs. RHHBF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RCDTF is a Hold and RHHBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (RCDTF: $65.44 vs. RHHBF: $314.81)
Brand notoriety: RCDTF and RHHBF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: RCDTF: 101% vs. RHHBF: 2%
Market capitalization -- RCDTF: $12.3B vs. RHHBF: $254.82B
RCDTF [@Pharmaceuticals: Major] is valued at $12.3B. RHHBF’s [@Pharmaceuticals: Major] market capitalization is $254.82B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $628.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RCDTF’s FA Score shows that 1 FA rating(s) are green whileRHHBF’s FA Score has 1 green FA rating(s).

  • RCDTF’s FA Score: 1 green, 4 red.
  • RHHBF’s FA Score: 1 green, 4 red.
According to our system of comparison, RCDTF is a better buy in the long-term than RHHBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RCDTF’s TA Score shows that 1 TA indicator(s) are bullish while RHHBF’s TA Score has 2 bullish TA indicator(s).

  • RCDTF’s TA Score: 1 bullish, 0 bearish.
  • RHHBF’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, RCDTF is a better buy in the short-term than RHHBF.

Price Growth

RCDTF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while RHHBF (@Pharmaceuticals: Major) price change was -1.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.35%. For the same industry, the average monthly price growth was +5.72%, and the average quarterly price growth was +12.95%.

Industries' Descriptions

@Pharmaceuticals: Major (+2.35% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RHHBF($255B) has a higher market cap than RCDTF($12.3B). RCDTF has higher P/E ratio than RHHBF: RCDTF (28.70) vs RHHBF (21.58). RCDTF YTD gains are higher at: 17.825 vs. RHHBF (4.525). RHHBF has higher annual earnings (EBITDA): 18B vs. RCDTF (819M). RHHBF has more cash in the bank: 12B vs. RCDTF (342M). RCDTF has less debt than RHHBF: RCDTF (2.47B) vs RHHBF (33B). RHHBF has higher revenues than RCDTF: RHHBF (63.5B) vs RCDTF (2.48B).
RCDTFRHHBFRCDTF / RHHBF
Capitalization12.3B255B5%
EBITDA819M18B5%
Gain YTD17.8254.525394%
P/E Ratio28.7021.58133%
Revenue2.48B63.5B4%
Total Cash342M12B3%
Total Debt2.47B33B7%
FUNDAMENTALS RATINGS
RCDTF vs RHHBF: Fundamental Ratings
RCDTF
RHHBF
OUTLOOK RATING
1..100
4864
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
58100
SMR RATING
1..100
4298
PRICE GROWTH RATING
1..100
4777
P/E GROWTH RATING
1..100
3658
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RHHBF's Valuation (11) in the null industry is in the same range as RCDTF (21). This means that RHHBF’s stock grew similarly to RCDTF’s over the last 12 months.

RCDTF's Profit vs Risk Rating (58) in the null industry is somewhat better than the same rating for RHHBF (100). This means that RCDTF’s stock grew somewhat faster than RHHBF’s over the last 12 months.

RCDTF's SMR Rating (42) in the null industry is somewhat better than the same rating for RHHBF (98). This means that RCDTF’s stock grew somewhat faster than RHHBF’s over the last 12 months.

RCDTF's Price Growth Rating (47) in the null industry is in the same range as RHHBF (77). This means that RCDTF’s stock grew similarly to RHHBF’s over the last 12 months.

RCDTF's P/E Growth Rating (36) in the null industry is in the same range as RHHBF (58). This means that RCDTF’s stock grew similarly to RHHBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RCDTFRHHBF
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
40%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
71%
Momentum
ODDS (%)
N/A
Bearish Trend 4 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
19%
Bearish Trend 4 days ago
56%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
18%
Bearish Trend 4 days ago
62%
Advances
ODDS (%)
N/A
Bullish Trend 26 days ago
59%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
56%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
56%
Aroon
ODDS (%)
Bullish Trend 4 days ago
14%
Bearish Trend 4 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
RCDTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RHHBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XERS7.680.38
+5.21%
Xeris Biopharma Holdings
GILD118.37-0.65
-0.55%
Gilead Sciences
BRT15.05-0.22
-1.44%
BRT Apartments Corp
ROAD107.57-5.05
-4.48%
Construction Partners
APWC1.79-0.14
-7.47%
Asia Pacific Wire & Cable Corp Ltd

RCDTF and

Correlation & Price change

A.I.dvisor tells us that RCDTF and RHHBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RCDTF and RHHBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCDTF
1D Price
Change %
RCDTF100%
N/A
RHHBF - RCDTF
3%
Poorly correlated
+0.99%
RHHBY - RCDTF
3%
Poorly correlated
+2.38%
PTKFY - RCDTF
0%
Poorly correlated
+1.99%
PTKFF - RCDTF
0%
Poorly correlated
N/A
SNPHY - RCDTF
-0%
Poorly correlated
+1.09%
More

RHHBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RHHBF has been loosely correlated with RHHBY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RHHBF jumps, then RHHBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RHHBF
1D Price
Change %
RHHBF100%
+0.99%
RHHBY - RHHBF
36%
Loosely correlated
+2.38%
RHHVF - RHHBF
29%
Poorly correlated
+4.32%
OTSKY - RHHBF
10%
Poorly correlated
+0.16%
PTKFY - RHHBF
6%
Poorly correlated
+1.99%
SNPHY - RHHBF
6%
Poorly correlated
+1.09%
More